KYAN Technologies to Present New Data at 2024 Rivkin Center and AACR Ovarian Cancer Research SymposiumSeptember 17, 2024
KYAN Technologies to Present New Data in Oral Minisymposium and Posters at AACR 2024 Annual MeetingMarch 26, 2024
KYAN Technologies Announces Presentation at the 2023 AACR-KCA Joint Conference on Precision Medicine in CancerNovember 14, 2023
KYAN Technologies to Present Functional Combinatorial Precision Medicine Platform Data at 2023 AACR-NCI-EORTC ConferenceOctober 10, 2023
Singapore becomes the first country to approve Optim.AI™, KYAN’s Personalized Medicine Solution for cancer patientsMay 29, 2023
Poster on clinical evaluation of combination-specific sub-population T-cell lymphoma presented at AACR 2023 Annual MeetingApril 1, 2023
Target prioritization and identification of novel nucleic acid therapies against MYC-driven HCC published in Bioengineering & Translational MedicineSeptember 1, 2022
KYAN Therapeutics and Curie Oncology Announce Strategic Collaboration to Provide Personalized Cancer Test in SingaporeMay 9, 2022
